CHS (CHSCL) Financials

CHSCL NASDAQ

Trailing 12 months to May 31, 2026

Revenue $37.4B +3.8% YoY

Net Income $577.5M +12.6% YoY

Free Cash Flow $932.9M n/m YoY

Operating Cash Flow $1.5B +208.1% YoY

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended May 31, 2026 Reported Jul 8, 2026 Currency USD FYE August

Newest figures come from the 10-Q for Q3 FY2026, filed Jul 8, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CHSCL SEC filings page.

CHS Inc (CHSCL) reported $37.4B in revenue over the twelve months to May 31, 2026, up 3.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CHSCL FY2025 2026-10-24

CHS operates on thin margins, and FY2025 cash generation no longer covered its capital reinvestment despite a reported profit.

FY2025 net income was $598M but free cash flow was -$93M, showing that accounting profit did not translate into cash available after investment. Operating cash flow of $636M fell below capital expenditures of $729M, making reinvestment the immediate source of the cash shortfall.

Margin compression amplified the downturn: from FY2023 to FY2025, revenue fell 22.2% while gross profit fell 52.2%. Gross margin narrowed from 5.2% in FY2023 to 3.2% in FY2025, leaving operating margin at only 0.3% and making profitability highly sensitive to product-cost spreads.

The balance-sheet posture strengthened even as earnings weakened: liabilities were 41.3% of assets and debt-to-equity was 0.2x in FY2025. A current ratio of 1.5x also indicates short-term assets remained above short-term obligations, so the main pressure appears operational and investment-related rather than driven by rising leverage.

Financial Health Signals

Financial Health Score 33/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of CHS Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

CHS Inc has an operating margin of 0.3%, meaning the company retains less than $1 of operating profit per $100 of revenue. This results in a moderate score of 39/100, indicating healthy but not exceptional operating efficiency. This is down from 1.5% the prior year.

Growth

CHS Inc's revenue declined 9.7% year-over-year, from $39.3B to $35.5B. This contraction results in a growth score of 8/100.

Leverage

CHS Inc has a moderate D/E ratio of 0.16. This balance of debt and equity financing earns a leverage score of 32/100.

Liquidity

CHS Inc's current ratio of 1.53 indicates adequate short-term liquidity, earning a score of 43/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

While CHS Inc generated $635.8M in operating cash flow, capex of $728.6M consumed most of it, leaving -$92.8M in free cash flow. This results in a low score of 31/100, reflecting heavy capital investment rather than weak cash generation.

Returns

CHS Inc's ROE of 5.4% shows moderate profitability relative to equity, earning a score of 44/100. This is down from 10.3% the prior year.

Piotroski F-Score Partial

4/8

CHS Inc passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.06x

For every $1 of reported earnings, CHS Inc generates $1.06 in operating cash flow ($635.8M OCF vs $597.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage At Risk

0.62x

CHS Inc earns $0.62 in operating income for every $1 of interest expense ($90.8M vs $146.1M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$11.6B

YoY+18.6%

QoQ+38.6%

5Y CAGR+1.2%

10Y CAGR+4.0%

CHS Inc generated $11.6B in revenue in Q3 2026. This represents an increase of 18.6% from the same quarter a year earlier. Against the prior quarter it is up 38.6%.

EBITDA

$273.7M

YoY+18.8%

QoQn/m

5Y CAGR+0.9%

10Y CAGR+0.3%

CHS Inc's EBITDA was $273.7M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 18.8% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Net Income

$267.4M

YoY+15.2%

QoQn/m

5Y CAGR-0.5%

10Y CAGR+3.5%

CHS Inc reported $267.4M in net income in Q3 2026. This represents an increase of 15.2% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)

Not reported for Q3 2026.

Cash & Balance Sheet

Free Cash Flow

$984.7M

YoY+89.1%

QoQn/m

5Y CAGR+18.1%

10Y CAGRn/m

CHS Inc generated $984.7M in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 89.1% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Debt

$497.6M

YoY+53.7%

QoQ+100.3%

5Y CAGR+10.6%

10Y CAGR+3.7%

CHS Inc held $497.6M in cash against $2.0B in long-term debt as of Q3 2026.

Shares Outstanding

YoYn/m

QoQn/m

5Y CAGRn/m

10Y CAGRn/m

CHS Inc had 0 shares outstanding in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin

3.5%

YoY+0.2pp

QoQ+3.2pp

5Y change+0.7pp

10Y change-0.5pp

CHS Inc's gross margin was 3.5% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.2 percentage points.

Operating Margin

0.9%

YoY+0.2pp

QoQ+3.8pp

5Y change-0.2pp

10Y change-1.0pp

CHS Inc's operating margin was 0.9% in Q3 2026, reflecting core business profitability. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.8 percentage points.

Net Margin

2.3%

YoY-0.1pp

QoQ+4.1pp

5Y change-0.2pp

10Y change-0.1pp

CHS Inc's net profit margin was 2.3% in Q3 2026, showing the share of revenue converted to profit. This is down 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.1 percentage points.

Return on Equity

2.4%

YoY+0.2pp

QoQ+3.7pp

5Y change-0.7pp

10Y change0.0pp

CHS Inc's quarterly ROE was 2.4% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.7 percentage points.

Capital Allocation

Capital Expenditures

$123.3M

YoY-29.9%

QoQ+17.5%

5Y CAGR+10.7%

10Y CAGR-0.5%

CHS Inc invested $123.3M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 29.9% from the same quarter a year earlier. Against the prior quarter it is up 17.5%.

R&D Spending

Not reported for Q3 2026.

Share Buybacks

Not reported for Q3 2026.

CHSCL Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CHSCL quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$37.4B	$35.5B-9.7%	$39.3B-13.9%	$45.6B-4.6%	$47.8B+24.3%	$38.4B+35.4%	$28.4B-11.0%	$31.9B-2.4%	$32.7B+2.0%	$32.0B+5.5%	$30.4B-12.2%	$34.6B-18.9%	$42.7B-4.1%	$44.5B+9.6%	$40.6B+10.0%	$36.9B
Cost of Revenue	$36.3B	$34.3B-8.5%	$37.5B-13.2%	$43.2B-5.4%	$45.7B+21.8%	$37.5B+36.7%	$27.4B-10.1%	$30.5B-3.4%	$31.6B+1.4%	$31.1B+6.0%	$29.4B-11.2%	$33.1B-19.3%	$41.0B-4.0%	$42.7B+10.7%	$38.6B+8.7%	$35.5B
Gross Profit	$1.2B	$1.1B-35.1%	$1.8B-26.3%	$2.4B+11.7%	$2.1B+123.6%	$951.4M-3.1%	$981.8M-29.1%	$1.4B+26.8%	$1.1B+22.2%	$893.9M-7.7%	$968.7M-35.0%	$1.5B-9.8%	$1.7B-7.1%	$1.8B-11.6%	$2.0B+43.4%	$1.4B
SG&A Expenses	$1.1B	$1.0B-10.4%	$1.2B+13.0%	$1.0B+3.5%	$997.8M+33.8%	$745.6M+5.8%	$704.5M-2.8%	$724.7M+13.3%	$639.8M+4.7%	$611.1M+1.6%	$601.3M-6.4%	$642.3M+6.6%	$602.6M+8.8%	$553.6M+11.1%	$498.2M+13.6%	$438.5M
Operating Income	$41.7M	$90.8M-84.5%	$584.4M-56.5%	$1.3B+19.0%	$1.1B+448.6%	$205.8M-25.8%	$277.3M-58.0%	$659.6M+45.8%	$452.4Mn/m	-$173.9M-159.5%	$292.4M-59.1%	$715.4M-31.9%	$1.0B-14.3%	$1.2B-19.0%	$1.5B+56.9%	$964.3M
EBITDA	N/A	$742.2M-35.7%	$1.2B-38.7%	$1.9B+18.4%	$1.6B+138.4%	$667.5M-11.5%	$754.6M-33.4%	$1.1B+21.8%	$930.4M+203.7%	$306.3M-58.6%	$739.9M-30.9%	$1.1B-21.0%	$1.4B-9.7%	$1.5B-13.3%	$1.7B+46.2%	$1.2B
Interest Expense	$179.9M	$146.1M+40.4%	$104.1M-24.3%	$137.4M+20.4%	$114.2M+9.2%	$104.6M-10.6%	$117.0M-30.0%	$167.1M+12.0%	$149.2M-12.9%	$171.2M+50.6%	$113.7M+60.9%	$70.7M-16.8%	$84.9M-14.5%	$99.3M+5.5%	$94.1M+13.3%	$83.0M
Income Tax	-$6.3M	$16.8Mn/m	-$4.9M-104.5%	$107.7M-18.5%	$132.1Mn/m	-$38.2Mn/m	-$36.7Mn/m	-$12.5Mn/m	-$104.1Mn/m	-$181.1M-1048.3%	$19.1Mn/m	-$12.2M-125.2%	$48.3M-46.1%	$89.7M+10.9%	$80.9M-6.7%	$86.6M
Net Income	$577.5M	$597.9M-45.8%	$1.1B-42.0%	$1.9B+13.2%	$1.7B+203.1%	$554.0M+31.1%	$422.4M-49.1%	$829.9M+7.0%	$775.9M+983.8%	$71.6M-81.3%	$383.2M-50.9%	$781.0M-27.8%	$1.1B+9.0%	$992.4M-21.3%	$1.3B+31.1%	$961.4M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Revenue	$11.6B+18.6%	$8.4B+7.2%	$8.9B-4.6%	$8.6B-6.2%	$9.8B+1.6%	$7.8B-14.2%	$9.3B-18.4%	$9.2B-3.3%
Cost of Revenue	$11.2B+18.4%	$8.3B+7.9%	$8.5B-4.7%	$8.3B-7.0%	$9.4B+3.2%	$7.7B-11.5%	$8.9B-17.2%	$8.9B-1.7%
Gross Profit	$410.6M+24.5%	$25.8M-66.2%	$389.4M-2.8%	$330.0M+21.0%	$329.8M-29.5%	$76.3M-79.1%	$400.7M-37.9%	$272.7M-37.8%
SG&A Expenses	$302.3M+16.8%	$267.6M+7.8%	$268.1M+2.0%	$276.1M-8.0%	$258.9M-18.2%	$248.3M-16.8%	$262.9M+4.3%	$300.2M+6.1%
Operating Income	$108.3M+52.7%	-$241.8Mn/m	$121.2M-12.0%	$53.9Mn/m	$71.0M-53.1%	-$172.0M-354.1%	$137.8M-64.9%	-$27.6M-117.7%
EBITDA	$273.7M+18.8%	-$69.2Mn/m	$292.1M+2.3%	$243.3M+101.7%	$230.3M-21.9%	-$16.9M-108.1%	$285.5M-46.2%	$120.6M-59.1%
Interest Expense	$49.7M+12.7%	$43.8M+73.6%	$37.4M+35.1%	$49.1M+92.2%	$44.1M+88.3%	$25.2M-1.0%	$27.6M-6.7%	$25.6M-18.3%
Income Tax	$14.7M-45.8%	-$17.8Mn/m	$11.7M-11.4%	-$14.9Mn/m	$27.2M+115.5%	-$8.7M-156.8%	$13.2Mn/m	-$26.3M-163.6%
Net Income	$267.4M+15.2%	-$147.1Mn/m	$260.5M+6.4%	$196.7M+75.9%	$232.2M-21.9%	-$75.8M-144.5%	$244.8M-53.2%	$111.8M-59.8%

Not reported in any period shown, so not listed: R&D Expenses, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

CHSCL Balance Sheet

CHSCL quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$18.9B+0.8%	$18.7B-1.3%	$19.0B+0.7%	$18.8B+7.1%	$17.6B+9.9%	$16.0B-2.8%	$16.4B+0.4%	$16.4B+3.6%	$15.8B-8.6%	$17.3B+13.7%	$15.2B-0.4%	$15.3B+13.3%	$13.5B-1.0%	$13.6B+11.7%	$12.2B
Current Assets	$8.1B-7.1%	$8.7B-4.6%	$9.1B-2.7%	$9.4B+17.2%	$8.0B+27.6%	$6.3B-5.9%	$6.7B-0.5%	$6.7B+18.9%	$5.6B-18.8%	$6.9B-13.4%	$8.0B-14.8%	$9.4B+5.5%	$8.9B-7.8%	$9.7B+10.6%	$8.7B
Cash & Equivalents	$327.8M-58.8%	$794.9M-55.0%	$1.8B+122.3%	$794.0M+92.2%	$413.2M+193.3%	$140.9M-33.3%	$211.2M-53.1%	$450.6M+148.4%	$181.4M-37.5%	$290.3M-70.0%	$967.7M-54.6%	$2.1B+18.0%	$1.8B+475.9%	$314.0M-66.5%	$937.7M
Short-Term Investments	$0-100.0%	$500.9Mn/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Inventory	$3.3B+6.6%	$3.1B-4.6%	$3.2B-12.0%	$3.7B+9.5%	$3.3B+21.6%	$2.7B-3.9%	$2.9B+3.1%	$2.8B+6.4%	$2.6B+9.7%	$2.4B-10.6%	$2.7B-3.9%	$2.8B+3.6%	$2.7B	N/A	N/A
Long-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Goodwill	$239.4M+33.0%	$180.0M0.0%	$180.0M0.0%	$180.0M+4.9%	$171.6M-0.5%	$172.4M0.0%	$172.4M+24.5%	$138.5M0.0%	$138.5M-4.0%	$144.3M-3.9%	$150.1M-5.4%	$158.7M+86.6%	$85.1M+4.1%	$81.7M+209.3%	$26.4M
Total Liabilities	$7.8B-2.2%	$8.0B-6.5%	$8.5B-9.2%	$9.4B+9.4%	$8.6B+19.3%	$7.2B-8.3%	$7.8B-4.7%	$8.2B+1.2%	$8.1B-14.1%	$9.5B+25.0%	$7.6B-14.4%	$8.8B+5.7%	$8.4B-8.9%	$9.2B+18.4%	$7.8B
Current Liabilities	$5.3B-2.2%	$5.4B-8.4%	$5.9B-15.1%	$7.0B+9.9%	$6.3B+28.6%	$4.9B-11.9%	$5.6B-5.9%	$5.9B+8.2%	$5.5B-15.9%	$6.5B+24.0%	$5.3B-15.6%	$6.2B+7.7%	$5.8B-15.2%	$6.8B+14.4%	$6.0B
Non-Current Liabilities	$2.5B-2.1%	$2.6B-2.0%	$2.6B+8.0%	$2.4B+7.8%	$2.2B-1.0%	$2.3B+0.5%	$2.3B-1.6%	$2.3B-13.3%	$2.6B-10.1%	$2.9B+27.0%	$2.3B-11.6%	$2.6B+1.2%	$2.6B+9.1%	$2.4B+31.7%	$1.8B
Long-Term Debt	$1.7B-4.3%	$1.8B+0.2%	$1.8B+9.1%	$1.7B+5.6%	$1.6B-1.4%	$1.6B-8.5%	$1.7B-0.7%	$1.8B-12.9%	$2.0B-2.9%	$2.1B+65.2%	$1.3B-10.2%	$1.4B-3.2%	$1.5B+8.9%	$1.3B-5.6%	$1.4B
Total Equity	$11.1B+3.0%	$10.8B+2.9%	$10.4B+10.5%	$9.5B+5.0%	$9.0B+2.3%	$8.8B+2.3%	$8.6B+5.6%	$8.2B+6.0%	$7.7B-2.0%	$7.9B+2.5%	$7.7B+18.8%	$6.4B+25.7%	$5.1B+15.2%	$4.5B0.0%	$4.5B
Retained Earnings	$3.0B+7.5%	$2.8B+10.6%	$2.5B+23.4%	$2.1B+19.9%	$1.7B+5.9%	$1.6B+2.1%	$1.6B+6.9%	$1.5B+16.9%	$1.3B-19.9%	$1.6B+6.5%	$1.5B-7.1%	$1.6B+15.8%	$1.4B	N/A	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Total Assets	$20.8B+5.5%	$20.9B+4.0%	$20.7B+6.0%	$18.9B+0.8%	$19.7B+6.7%	$20.1B+4.9%	$19.6B-4.2%	$18.7B-1.3%
Current Assets	$9.9B+11.4%	$10.3B+5.8%	$9.9B+5.8%	$8.1B-7.1%	$8.9B+5.5%	$9.7B+4.0%	$9.4B-11.6%	$8.7B-4.6%
Cash & Equivalents	$497.6M+53.7%	$248.5M-42.7%	$374.7M-16.8%	$327.8M-58.8%	$323.9M+4.4%	$433.3M-31.6%	$450.5M-66.6%	$794.9M-55.0%
Short-Term Investments	$0n/m	$0n/m	$0-100.0%	$0-100.0%	$0n/m	$0n/m	$345.2Mn/m	$500.9Mn/m
Inventory	$3.6B+4.5%	$4.9B+5.2%	$4.3B+10.9%	$3.3B+6.6%	$3.5B+4.4%	$4.6B+18.1%	$3.9B-8.2%	$3.1B-4.6%
Long-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m
Goodwill	N/A	N/A	N/A	$239.4M+33.0%	N/A	N/A	N/A	$180.0M0.0%
Total Liabilities	$9.6B+7.6%	$9.9B+4.9%	$9.5B+8.9%	$7.8B-2.2%	$8.9B+17.9%	$9.4B+11.8%	$8.8B-10.0%	$8.0B-6.5%
Current Liabilities	$6.8B+6.5%	$7.1B+4.4%	$7.0B+14.8%	$5.3B-2.2%	$6.4B+22.1%	$6.8B+14.8%	$6.1B-12.9%	$5.4B-8.4%
Non-Current Liabilities	$2.8B+10.3%	$2.8B+6.2%	$2.6B-4.5%	$2.5B-2.1%	$2.5B+8.6%	$2.6B+4.5%	$2.7B-2.9%	$2.6B-2.0%
Long-Term Debt	$2.0B+8.6%	$2.0B+8.5%	$1.7B-4.5%	$1.7B-4.3%	$1.8B+9.4%	$1.8B+9.4%	$1.8B+0.2%	$1.8B+0.2%
Total Equity	$11.2B+3.9%	$11.1B+3.2%	$11.2B+3.6%	$11.1B+3.0%	$10.8B-1.1%	$10.7B-0.5%	$10.8B+1.1%	$10.8B+2.9%
Retained Earnings	$3.2B+5.1%	$3.0B+5.3%	$3.2B+8.3%	$3.0B+7.5%	$3.0B-5.1%	$2.8B-4.8%	$2.9B+1.3%	$2.8B+10.6%

Not reported in any period shown, so not listed: Accounts Receivable.

CHSCL Cash Flow Statement

CHSCL quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$1.5B	$635.8M-50.1%	$1.3B-61.2%	$3.3B+68.7%	$1.9B+156.9%	$757.8M-30.3%	$1.1B-4.6%	$1.1B+6.1%	$1.1B+12.5%	$954.7M-24.3%	$1.3B+121.1%	$570.0M-60.5%	$1.4B-41.7%	$2.5B+244.1%	$718.6M+138.5%	$301.3M
Depreciation & Amortization	N/A	$651.4M+14.3%	$569.9M+5.6%	$539.5M+16.8%	$462.0M+0.1%	$461.7M-3.3%	$477.4M+0.9%	$473.2M-1.0%	$478.1M-0.5%	$480.2M+7.3%	$447.5M+25.9%	$355.4M+16.1%	$306.2M+10.7%	$276.6M+25.9%	$219.6M-0.5%	$220.7M
Capital Expenditures	$539.4M	$728.6M-9.9%	$808.8M+43.3%	$564.5M+59.3%	$354.4M+11.5%	$317.8M-24.0%	$418.4M-5.6%	$443.2M+24.7%	$355.4M-20.0%	$444.4M-35.9%	$692.8M-41.6%	$1.2B+29.1%	$919.1M+48.3%	$619.9M+32.3%	$468.6M+50.8%	$310.7M
Free Cash Flow	$932.9M	-$92.8M-120.0%	$464.1M-82.9%	$2.7B+70.8%	$1.6B+261.8%	$440.0M-34.2%	$668.9M-4.0%	$696.7M-3.1%	$719.1M+40.9%	$510.3M-10.1%	$567.8Mn/m	-$616.8M-218.1%	$522.2M-71.8%	$1.9B+641.2%	$250.0Mn/m	-$9.3M
Investing Cash Flow	-$832.1M	-$880.6Mn/m	-$1.4Bn/m	-$950.2Mn/m	-$457.1Mn/m	-$101.7Mn/m	-$243.7Mn/m	-$661.3Mn/m	-$79.5Mn/m	-$405.0Mn/m	-$3.7Bn/m	-$1.9Bn/m	-$1.3Bn/m	-$495.3Mn/m	-$694.2Mn/m	-$551.0M
Financing Cash Flow	-$444.2M	-$230.6Mn/m	-$814.3Mn/m	-$1.4Bn/m	-$1.1Bn/m	-$326.6Mn/m	-$931.1Mn/m	-$725.6Mn/m	-$732.2Mn/m	-$618.3M-134.1%	$1.8B+1079.4%	$153.8M-23.6%	$201.4Mn/m	-$478.0Mn/m	-$638.9M-181.2%	$786.9M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Cash Flow	$1.1B+59.1%	-$569.0Mn/m	-$337.8Mn/m	$1.3B+14.2%	$696.6M+25.1%	-$1.0Bn/m	-$294.0Mn/m	$1.1B-15.3%
Depreciation & Amortization	$165.3M+3.7%	$172.6M+11.4%	$170.8M+15.7%	$189.3M+27.8%	$159.4M+11.1%	$155.0M+10.6%	$147.7M+7.0%	$148.2M+131.0%
Capital Expenditures	$123.3M-29.9%	$105.0M-36.4%	$116.0M-39.8%	$195.1M-27.0%	$175.9M-9.9%	$164.9M-19.0%	$192.7M+35.3%	$267.4M+40.5%
Free Cash Flow	$984.7M+89.1%	-$674.0Mn/m	-$453.8Mn/m	$1.1B+27.2%	$520.6M+44.0%	-$1.2Bn/m	-$486.6Mn/m	$845.8M-24.8%
Investing Cash Flow	-$298.4Mn/m	$42.6Mn/m	-$247.9Mn/m	-$328.4Mn/m	-$506.3Mn/m	-$39.2Mn/m	-$6.7Mn/m	-$912.1Mn/m
Financing Cash Flow	-$525.2Mn/m	$392.1M-63.3%	$644.2Mn/m	-$955.3M-439.6%	-$307.5Mn/m	$1.1Bn/m	-$36.0Mn/m	$281.3Mn/m

Not reported in any period shown, so not listed: Stock-Based Compensation, Dividends Paid, Share Buybacks.

CHSCL Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CHSCL quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	3.2%-1.3pp	4.5%-0.8pp	5.2%+0.8pp	4.5%+2.0pp	2.5%-1.0pp	3.5%-0.9pp	4.3%+1.0pp	3.3%+0.5pp	2.8%-0.4pp	3.2%-1.1pp	4.3%+0.4pp	3.9%-0.1pp	4.0%-1.0pp	5.0%+1.2pp	3.8%
Operating Margin	0.3%-1.2pp	1.5%-1.5pp	2.9%+0.6pp	2.4%+1.8pp	0.5%-0.4pp	1.0%-1.1pp	2.1%+0.7pp	1.4%+1.9pp	-0.5%-1.5pp	1.0%-1.1pp	2.1%-0.4pp	2.5%-0.3pp	2.8%-1.0pp	3.7%+1.1pp	2.6%
Net Margin	1.7%-1.1pp	2.8%-1.4pp	4.2%+0.7pp	3.5%+2.1pp	1.4%-0.1pp	1.5%-1.1pp	2.6%+0.2pp	2.4%+2.1pp	0.2%-1.0pp	1.3%-1.0pp	2.3%-0.3pp	2.5%+0.3pp	2.2%-0.9pp	3.1%+0.5pp	2.6%
Return on Equity	5.4%-4.8pp	10.3%-7.9pp	18.2%+0.4pp	17.8%+11.6pp	6.2%+1.3pp	4.8%-4.8pp	9.6%+0.1pp	9.5%+8.6pp	0.9%-4.0pp	4.9%-5.3pp	10.2%-6.6pp	16.8%-2.6pp	19.3%-8.9pp	28.3%+6.7pp	21.6%
Return on Assets	3.2%-2.7pp	5.9%-4.1pp	10.0%+1.1pp	8.9%+5.8pp	3.1%+0.5pp	2.6%-2.4pp	5.1%+0.3pp	4.7%+4.3pp	0.4%-1.8pp	2.2%-2.9pp	5.1%-1.9pp	7.1%-0.3pp	7.3%-1.9pp	9.2%+1.4pp	7.9%
Current Ratio	1.53-0.1x	1.61+0.1x	1.55+0.2x	1.35+0.1x	1.260.0x	1.27+0.1x	1.19+0.1x	1.13+0.1x	1.030.0x	1.06-0.5x	1.520.0x	1.510.0x	1.54+0.1x	1.420.0x	1.47
Debt-to-Equity	0.160.0x	0.170.0x	0.170.0x	0.180.0x	0.180.0x	0.180.0x	0.200.0x	0.220.0x	0.260.0x	0.27+0.1x	0.16-0.1x	0.22-0.1x	0.280.0x	0.300.0x	0.32
Liabilities-to-Equity	0.700.0x	0.74-0.1x	0.81-0.2x	0.990.0x	0.95+0.1x	0.82-0.1x	0.91-0.1x	1.010.0x	1.06-0.1x	1.20+0.2x	0.99-0.4x	1.37-0.3x	1.63-0.4x	2.06+0.3x	1.74
Asset Turnover	1.88-0.2x	2.10-0.3x	2.40-0.1x	2.54+0.4x	2.19+0.4x	1.78-0.2x	1.94-0.1x	2.000.0x	2.03+0.3x	1.75-0.5x	2.27-0.5x	2.79-0.5x	3.29+0.3x	2.980.0x	3.02
FCF Margin	-0.3%-1.4pp	1.2%-4.8pp	6.0%+2.6pp	3.3%+2.2pp	1.1%-1.2pp	2.4%+0.2pp	2.2%0.0pp	2.2%+0.6pp	1.6%-0.3pp	1.9%+3.7pp	-1.8%-3.0pp	1.2%-2.9pp	4.2%+3.6pp	0.6%+0.7pp	0.0%

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Gross Margin	3.5%+0.2pp	0.3%-0.7pp	4.4%+0.1pp	3.8%+0.9pp	3.4%-1.5pp	1.0%-3.1pp	4.3%-1.3pp	3.0%-1.6pp
Operating Margin	0.9%+0.2pp	-2.9%-0.7pp	1.4%-0.1pp	0.6%+0.9pp	0.7%-0.9pp	-2.2%-3.0pp	1.5%-2.0pp	-0.3%-1.9pp
Net Margin	2.3%-0.1pp	-1.8%-0.8pp	2.9%+0.3pp	2.3%+1.1pp	2.4%-0.7pp	-1.0%-2.8pp	2.6%-2.0pp	1.2%-1.7pp
Return on Equity	2.4%+0.2pp	-1.3%-0.6pp	2.3%+0.1pp	1.8%+0.7pp	2.1%-0.6pp	-0.7%-2.3pp	2.3%-2.6pp	1.0%-1.6pp
Return on Assets	1.3%+0.1pp	-0.7%-0.3pp	1.3%0.0pp	1.0%+0.4pp	1.2%-0.4pp	-0.4%-1.3pp	1.3%-1.3pp	0.6%-0.9pp
Current Ratio	1.47+0.1x	1.450.0x	1.42-0.1x	1.53-0.1x	1.40-0.2x	1.43-0.1x	1.540.0x	1.61+0.1x
Debt-to-Equity	0.180.0x	0.180.0x	0.160.0x	0.160.0x	0.170.0x	0.170.0x	0.170.0x	0.170.0x
Liabilities-to-Equity	0.850.0x	0.890.0x	0.850.0x	0.700.0x	0.83+0.1x	0.88+0.1x	0.81-0.1x	0.74-0.1x
Asset Turnover	0.56+0.1x	0.400.0x	0.430.0x	0.460.0x	0.500.0x	0.39-0.1x	0.47-0.1x	0.490.0x
FCF Margin	8.5%+3.2pp	-8.1%+7.4pp	-5.1%+0.1pp	12.5%+3.3pp	5.3%+1.6pp	-15.4%-10.4pp	-5.2%-2.7pp	9.2%-2.6pp

Where CHS Inc Ranks

Frequently Asked Questions

What is CHS Inc's annual revenue?

CHS Inc (CHSCL) reported $35.5B in total revenue for fiscal year 2025. This represents a -9.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is CHS Inc's revenue growing?

CHS Inc (CHSCL) revenue declined by 9.7% year-over-year, from $39.3B to $35.5B in fiscal year 2025.

Is CHS Inc profitable?

Yes, CHS Inc (CHSCL) reported a net income of $577.5M over the trailing 12 months to May 31, 2026. In fiscal year 2025 it reported a net income of $597.9M, with a net profit margin of 1.7%.

What is CHS Inc's EBITDA?

CHS Inc (CHSCL) had EBITDA of $742.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does CHS Inc have?

As of fiscal year 2025, CHS Inc (CHSCL) had $327.8M in cash and equivalents against $1.7B in long-term debt.

What is CHS Inc's gross margin?

CHS Inc (CHSCL) had a gross margin of 3.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is CHS Inc's operating margin?

CHS Inc (CHSCL) had an operating margin of 0.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is CHS Inc's net profit margin?

CHS Inc (CHSCL) had a net profit margin of 1.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is CHS Inc's return on equity (ROE)?

CHS Inc (CHSCL) has a return on equity of 5.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is CHS Inc's free cash flow?

CHS Inc (CHSCL) recorded an outflow of $92.8M in free cash flow during fiscal year 2025. This represents a -120.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is CHS Inc's operating cash flow?

CHS Inc (CHSCL) generated $635.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are CHS Inc's total assets?

CHS Inc (CHSCL) had $18.9B in total assets as of fiscal year 2025, including both current and long-term assets.

What are CHS Inc's capital expenditures?

CHS Inc (CHSCL) invested $728.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does CHS Inc have outstanding?

CHS Inc (CHSCL) had 0 shares outstanding as of fiscal year 2025.

What is CHS Inc's current ratio?

CHS Inc (CHSCL) had a current ratio of 1.53 as of fiscal year 2025, which is generally considered healthy.

What is CHS Inc's debt-to-equity ratio?

CHS Inc (CHSCL) had a debt-to-equity ratio of 0.16 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

What is CHS Inc's liabilities-to-equity ratio?

CHS Inc (CHSCL) had a liabilities-to-equity ratio of 0.70 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

What is CHS Inc's return on assets (ROA)?

CHS Inc (CHSCL) had a return on assets of 3.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is CHS Inc's Piotroski F-Score?

CHS Inc (CHSCL) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are CHS Inc's earnings high quality?

CHS Inc (CHSCL) has an earnings quality ratio of 1.06x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can CHS Inc cover its interest payments?

CHS Inc (CHSCL) has an interest coverage ratio of 0.62x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is CHS Inc?

CHS Inc (CHSCL) scores 33 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.